OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

173.73 RMD shares were withheld to cover taxes or exercise cost (Officer) | OQRO

Home
Insider trades
ResMed|
173.73 RMD shares were withheld to cover taxes or exercise cost (Offic

Insider trades

Insider trade

173.73 RMD shares were withheld to cover taxes or exercise cost (Officer)

Traded Nov 11, 2025 · Filed Nov 14, 2025

RMDResMed|RMD

173.73
Shares · @ $250.10

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 11, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 14, 2025

OfficerTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000943819-25-000096

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Nov 14, 2025, 12:23 AM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

RESMED INC

Issuer CIK

943819

Ticker

RMD

Reporting person

Michael J Rider

Relationship

Officer

Officer title

Global General Counsel

Security

ResMed Common Stock

Table

Non-derivative (Table I)

Transaction date

Nov 11, 2025

Transaction code

Shares / units

173.725

Price per share

$250.10

Acquired / disposed

Disposed (D)

Shares owned after

11,057

Ownership form

Direct

Amendment

Footnotes from the filing

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.

Around the same time

Michael J. FarrellChairman and CEO

Filed 10mo ago

4,991Shares · @ $146.34

Traded Dec 8, 2025 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Michael J. Farrell (Chairman and CEO) sold ~$1.25M of ResMed|

Scheduled in advanceFiled 10mo ago

Michael J. FarrellChairman and CEO

Filed 10mo ago

4,991Derivative units

Traded Dec 8, 2025 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record